Twitxy Saved

Science Advancement and Outreach

Verified account This account is verified. Learn more

@SAOscience

Promoting human-relevant research, policies, and funding opportunities. Better for patients, better for animals.
Washington DC scienceadvancement.org Joined September 2022
955 Following 1.3K Followers 5.2K Posts

Latest posts 5

Pinned post

Science Advancement and Outreach Verified account @SAOscience
Wondering why we've been talking so much about the new Research Modernization NOW website? This short video explains its value, and who it’s for.

A resource designed for multiple audiences:

✍️ Journalists and authors
Reporting on animal testing, non-animal methods, biomedical research, or any of the 15 disease areas covered. It also provides context on recent NIH and FDA developments, oversight systems (including IACUCs), and the implications of the scientific evidence on animal sentience.

🧑‍🎓 Students
A reliable starting point for reports, or for building a foundational understanding of these issues.

🧑‍🏫 Educators
Content to support teaching on research methods, ethics, and emerging scientific approaches.

🧑‍💼 Policymakers and staff
Background research and policy-relevant insights to inform legislative priorities and decisions.

🧑‍⚕️ Healthcare professionals
A way to stay current on the scientific and regulatory landscape, and to engage in efforts advancing human‑relevant science.

🐾 Animal advocates
Credible, evidence-based information to deepen understanding of animal use in research and testing, and to strengthen advocacy for modern, non-animal approaches.

This structured, evidence-based resource is for anyone working at the intersection of science, policy, and ethics, and for those helping drive the transition to human-relevant research.

🎞️ Watch the video to see how it can support your work.

youtu.be/wCT9OTnSUk8
0:54
Science Advancement and Outreach Verified account @SAOscience
Researchers at @EmoryMedicine developed a human organoid model that captures key features of oligodendrocyte development and dysfunction, opening new possibilities for studying multiple sclerosis and other neurological diseases in a complex, human cellular environment.

Using human stem cell-derived spinal cord organoids and cortico-motor assembloids, the team generated cells spanning multiple stages of oligodendrocyte development. Single-cell RNA sequencing of more than 15,000 cells showed that these populations closely resembled those found in the developing human spinal cord.

The models also reproduced important cell behaviors. Oligodendrocyte precursor cells migrated into neighboring cortical tissue, and the researchers demonstrated direct synaptic connections between neurons and oligodendrocyte-lineage cells, which the authors describe as the first in vitro investigation of neuron-oligodendrocyte synapses.

When assembloids were exposed to inflammation, the oligodendrocytes developed stress- and disease-associated changes. 42% of genes upregulated in a disease-associated oligodendrocyte population identified in human multiple sclerosis brain tissue were also upregulated in the assembloids.

These models could be used for investigating mechanisms and potential therapies for neuroinflammatory disorders.

Congratulations to the authors, including Taylor Pio, @emileadingstrnd, @Sloan_Lab, @jimena_andersen on this exciting advance in human neuroscience (and on the cover image for this issue of @stemcellreports!)

🏛️ @BrainOrg_Hub, @EmoryGenetics, @GoizuetaADRC, @EmoryPediatrics

This work was funded by @NIH and the Congressionally Directed Medical Research Programs
Science Advancement and Outreach Verified account @SAOscience
The lack of awareness of model assessment tools is a major roadblock to the paradigm shift.

A new survey in NAM Journal highlights a persistent challenge in biomedical research: findings from animal experiments fail to translate into meaningful benefits for patients, but awareness of existing translational assessment tools remains limited.

“Several factors undermine the translatability of preclinical research, including the limited capacity of non-human animal models … to capture the complexity of human physiology, disease mechanisms, systemic interactions, and population-level heterogeneity.”

Francesca Pistollato et al. surveyed 105 researchers and other biomedical professionals. They found that 93% considered tools for assessing the translational relevance of models important, and 77% rated model relevance to human physiology as a “very important” criterion for evaluating models. Yet 35% were completely unaware of existing assessment tools that can help appraise model performance, evaluate risk of bias and internal validity, inform go/no-go decisions, identify opportunities for animal replacement, and more.

The vast majority of animal “models” have never been evaluated for their translatability to humans.

The authors suggest incorporating AI-driven approaches to increase awareness and facilitate the uptake of existing tools, potentially guiding users toward approaches to identifying animal-replacement opportunities. ✨ 

👉 Read the paper: sciencedirect.com/science/articl…
Science Advancement and Outreach Verified account @SAOscience
🦇 Wild bats are being captured, sampled from, and killed in an attempt to answer questions about zoonotic disease. In a new systematic review in @AW_TheJournal, Carlotta Pasetto et al. show how widespread these practices remain. doi.org/10.1017/awf.20…

Researchers examined 226 studies involving the capture and sampling of wild bats for zoonotic disease experiments between 2014 and 2024. Nearly half reported euthanizing bats. Blood sampling occurred in 18.6% of studies, while anesthesia was reported in 20.3%. Notably, 55% of studies that reported euthanasia involved one or more species classified by the IUCN as being of conservation concern.

There are obvious animal welfare concerns, as well as scientific problems. The authors wrote, "a relatively high proportion (46.3%) of research papers did not describe key methodological details, making it not possible to assess their compliance with recommended practices. Another 15.0% of the articles used methods recognised as Not compliant."

Research intended to protect public health should meet rigorous standards for methodology and transparency, and should not reduce animal welfare. Prioritizing non-invasive approaches over invasive experiments on animals should be a foremost goal.

For zoonotic surveillance, this means advancing methods that can obtain pathogen data while minimizing capture and avoiding invasive sampling and killing of wildlife. Protecting human health and protecting wild animals should be part of the same scientific objective.

"The collapse of more than 70% of global wildlife populations over the past 50 years, is yet another stark confirmation of the ongoing biodiversity crisis. ... This context calls for an urgent shift toward more ethical and conservation-aware approaches to wildlife research."

🏛️ Wildlife Conservation Medicine Research Group of the @UABBarcelona, @CReSA_r, @ctforestal, and @uvic_ucc's BETA Technological Centre

#AnimalWelfare #WildlifeResearch #PublicHealth
Science Advancement and Outreach Verified account @SAOscience
What happens in frontotemporal dementia before tau pathology appears? 🧠

In a new study, researchers from @NeuralStemCells demonstrated how carefully standardized human cortical organoids can help identify early molecular changes that precede tau pathology.

Bertucci et al. built a scalable platform using hiPSCs carrying disease-associated MAPT mutations and their isogenic controls. By improving organoid manufacturing, cortical patterning, and quality control, they generated organoids with gene-expression profiles that closely resembled those of the developing human cortex, with minimal evidence of culture-related cellular stress.

Their quality control system, CortiCOSI, helped identify organoids that developed consistent cortical characteristics. Focusing on these organoids revealed disease-associated molecular changes that had been obscured by variability across samples. In MAPT V337M organoids, the researchers identified early dysregulation of PP2A signaling and prefoldin function that preceded the tau hyperphosphorylation and oligomerization observed at later time points.

By reducing the experimental variability that can obscure subtle biological signals, this platform could make it easier to identify early disease mechanisms and investigate how tau-related disease unfolds over time in human cells.

In @Nature_NPJ npj dementia:
🔗 nature.com/articles/s4440…

Congratulations to the researchers and collaborators, including Sally Temple, Steven Lotz, @GeschwindLab, @KateTubbesing, @karchlab, and others.

🏛️ NSCI, @UKDRI, @dgsomucla, @SinaiGenetics, @SinaiGenHealth, @CGM_MGH, @CompHealthMuc, @ETH_BSSE, @WashUMedADRC

This work was funded by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), @RCFNeuro, @tau_consortium, @AFTDHope, @_BrightFocus, @CurePSP, UKDRI, and @MALifeSciences.

#RareDisease
www.nature.com Integrated manufacturing platform for cortical organoids reveals early phosphatase and prefoldin... npj Dementia - Integrated manufacturing platform for cortical organoids reveals early phosphatase and prefoldin dysregulation in MAPT V337M neurons